Name: UMIN ID:
Unique ID issued by UMIN | UMIN000043994 |
---|---|
Receipt number | R000050243 |
Scientific Title | Comparative efficacy and safety of lorlatinib and alectinib for ALK rearrangement positive advanced non-small cell lung cancer in Asian and non-Asian patients: systematic review and network meta-analysis. |
Date of disclosure of the study information | 2021/04/22 |
Last modified on | 2021/06/26 10:43:28 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2021/04/21 10:25:56 | ||
2 | Update | 2021/06/02 10:06:57 | Public title Public title Scientific Title Scientific Title |
|
3 | Update | 2021/06/02 10:19:57 | Narrative objectives1 Narrative objectives1 Primary outcomes Primary outcomes Key secondary outcomes Key secondary outcomes |
|
4 | Update | 2021/06/02 10:23:51 | Key inclusion criteria Key inclusion criteria Key exclusion criteria Key exclusion criteria |
|
5 | Update | 2021/06/26 10:29:50 | Recruitment status Date of IRB |
|
6 | Update | 2021/06/26 10:40:23 | Number of participants that the trial has enrolled |
|
7 | Update | 2021/06/26 10:43:28 | Last follow-up date |